Ⅰ型胶原对巨噬细胞摄取氧化低密度脂蛋白的作用

为探讨胶原的存在对细胞摄取氧化低密度脂蛋白（ｏｘ－ＬＤＬ）的影响,本研究在体外制成Ⅰ型胶原凝胶和巨噬细胞实验体系。ＬＤＬ经Ｃｕ２＋催化氧化,丙二醛（ＭＤＡ）及乙酰化修饰后,与胶原的结合能力明显增强,但４－羟基壬烯醛（ＨＮＥ）修饰的ＬＤＬ与胶原的结合能力反而不如天然ＬＤＬ。当小鼠腹腔巨噬细胞培养在胶原凝胶上时,其对ｏｘ－ＬＤＬ的摄取明显减少,这时大部分ｏｘ－ＬＤＬ为胶原凝胶所结合。如用细胞松弛素Ｄ（细胞非特异性吞噬抑制剂）处理巨噬细胞,在无胶原存在时,可见细胞对ｏｘ－ＬＤＬ的降解明显减少;而有胶原时,细胞的降解量则无明显变化,其水平与无胶原时的细胞处理组相当。上述结果提示,Ⅰ型胶原的存在可能阻止了巨噬细胞通过非特异性吞噬途径摄取ｏｘ－ＬＤＬ。     

A群链球菌的研究进展

自８０年代中期以来,由Ａ群链球菌引起的感染有增多趋势,甚至呈暴发流行。现已证实,该菌出现了侵袭力极强的强毒株,所引起的疾病类似于葡萄球菌毒休克综合征已证实,该菌出现了侵袭力极强的强毒株,所引起的疾病类似于葡萄球菌毒素休克综合征（ＴＳＳ）,故称为毒素休克样综合征（ＴＳＬＳ）。本文就近１０年来,ＴＳＬＳ的临床表现与致病机制、Ａ群链球菌起抗原、粘附机制以及Ｍ蛋白疫苗研制进展作一简介。     

免疫共沉淀筛选细胞内与A型流感病毒M2蛋白相互作用的蛋白

摘要：【目的】筛选细胞内与A型流感病毒M2蛋白（A/M2）相互作用的蛋白质。【方法】将A/M2编码序列插入真核表达载体pCAGGS-CFlag,重组质粒pCAGGS-CFlag-A/M2转染HEK-293T细胞,裂解细胞,以Flag单抗偶联的琼脂糖球珠免疫沉淀A/M2-Flag蛋白,清洗去除非特异性结合的杂蛋白后,SDS-PAGE银染法显示与A/M2共沉淀的蛋白,从胶上切下此蛋白条带进行质谱分析。【结果】成功构建了A/M2的表达质粒,免疫印迹证实了A/M2蛋白在293T细胞中能够表达,免疫共沉淀筛选到与A/M2结合的多种蛋白,分析质谱结果,确定ataxin 10和3个真核翻译起始因子(eIF)为候选蛋白。【结论】ataxin 10与A/M2相互作用为流感病毒感染或接种流感疫苗引发小脑性共济失调提供了解释,eIF与A/M2相互作用表明A/M2可能在调控病毒蛋白合成方面起重要作用。     

86株A群链球菌耐药性检测与分析

目的探讨A群链球菌对多种抗生素的耐药性,更好地指导临床用药。方法收集本院2005年度检出的39株和2006年度检出的47株A群链球菌的药物敏感试验结果,使用X^2检验比较A群链球菌耐药率。结果2006年度和上一年度相比A群链球菌对红霉素、克林霉素、阿齐霉素的耐药率增高显著（P〈0．05）,而对氯霉素、四环素的耐药性无明显改变（P〉0．05）,未发现耐万古霉素、青霉素、头孢吡肟、头孢噻肟的菌株。结论加强对A群链球菌耐药性检测及调查分析,对指导临床用药有重要意义。     

雌激素受体与Ⅰ型胶原蛋白存在相互作用

目的:利用酵母双杂交技术筛选与雌激素受体(ER)αAF1转录激活结构域相互作用的蛋白,为乳腺癌发生、发展机制的研究奠定基础。方法:将编码ERαAF1的cDNA片段克隆到诱饵蛋白载体pGBKT7中,以构建的pGBKT7-ERα-AF1为表达靶蛋白的质粒,筛选人乳腺文库。将筛选到的含Ⅰ型胶原基因的质粒与表达ERα和ERβ不同结构域的质粒共转化酵母细胞,验证Ⅰ型胶原与ERαAF1作用的特异性。结果:经酶切鉴定,证实重组质粒pGBKT7-ERα-AF1含有目的基因片段;Western印迹证实ERαAF1在酵母中获得表达;酵母双杂交筛选得到与ERαAF1相互作用的Ⅰ型胶原蛋白。酵母细胞共转化实验证实,Ⅰ型胶原蛋白与ERα和ERβ的AF1结合,但与ERβ的DBD、AF2不结合。结论:Ⅰ型胶原与ERα和ERβ的AF1及ERβ的DBD存在相互作用。     

肺炎链球菌假想的溶菌酶样蛋白的活性分析和鉴定

目的 探索肺炎链球菌中一种假想的溶菌酶样蛋白的活性.方法 生物信息学分析该基因的功能结构域;利用长臂同源PCR对该基因进行敲除,观察D39野生菌和缺陷菌在生物学性状的改变;利用底物PNP-（GIcNAc）和溶壁微球菌,构建过表达载体,绘制生长曲线,对截断和全长蛋白的溶菌酶活性进行鉴定.结果 生物信息学分析结果显示该基因的编码产物为β-1,4-N-乙酰胞壁酸糖苷酶,属于糖基水解酶25家族;野生菌为长链生长,缺陷菌呈短链状;溶菌酶和假想的溶菌酶样蛋白均可使底物释放出游离的对硝基苯酚,A405nm吸光度值分别为1.166和0.792;同时也可使得溶壁微球菌发生溶解;含过表达质粒的肺炎链球菌较之野生菌,溶解较快.结论 假想的溶菌酶样蛋白具有溶菌酶活性,是一种新的溶菌酶.     

A型流感病毒NS1蛋白与宿主的相互作用

A型流感病毒非结构蛋白1(nonstructural protein l, NS1)全长约为230个氨基酸,主要包括两个功能结构域,即 N-末端的RNA结合结构域和C-末端的效应结构域.NS1是一个多功能病毒蛋白,它不仅影响着该病毒其他基因的表达,更能通过与宿主细胞多种因子的相互作用干预宿主细胞的正常功能,抵抗宿主的抗病毒系统.因此, NS1被认为是A型流感病毒的一个重要毒力因子.本文综述了 NS1蛋白与宿主相互作用的最新研究进展,为进一步揭示NS1 蛋白的功能提供了参考.     

MMP-2与Ⅰ型胶原关系的研究进展

MMP-2与I型胶原分别为基质金属蛋白酶家族的重要成员和细胞外基质的主要成分,近年来研究发现,MMP-2与Ⅰ型胶原的表达与调控在多种与胶原代谢有关的疾病中起着重要作用。通过增强或抑制MMP-2来调控I型胶原,进而防止疾病的发生发展已成为很多疾病的研究热点。对MMP-2与Ⅰ型胶原关系更新的认识也引起了越来越多的关注,必然带动对MMP-2与Ⅰ型胶原更深层次的研究,本文就近年来有关MMP-2与Ⅰ型胶原的研究进展做一综述,为多种胶原代谢疾病发病机理与防治的探究提供新的思路和理论依据。     

一种溶菌酶样蛋白对肺炎链球菌毒力及荚膜多糖合成的影响

摘要：【目的】为了研究肺炎链球菌（Streptococcus pneumoniae, S.pn）的一种假想的溶菌酶样蛋白在细菌生物学性状及其致病中的作用。【方法】利用长臂同源PCR对该基因进行敲出,并同时构建带有拯救质粒的缺失菌株,观察D39野生菌、缺失菌与带有拯救质粒的缺失菌株在相关生物学性状及其致病力改变,从而鉴定这种假想溶菌酶样蛋白的功能。【结果】缺失菌与野生菌相比,细菌生长减缓,毒力下降,荚膜多糖合成明显减少。而将拯救质粒转入缺失菌株后,该溶菌酶样蛋白的mRNA表达水平较野生菌高,其毒力及荚膜合成     

FoxO1 对肝脏脂代谢的影响

Fox O1是叉头转录家族O亚族的一员,因其对胰岛素作用起重要的调控作用而被人所熟知,越来越多的研究表明,Fox O1对于肝脏脂质代谢也起重要的调控作用,其作用机制可能是通过上调微粒体甘油三酯转运蛋白(MTP)、载脂蛋白B(Apo B)的表达,从而促进极低密度脂蛋白(VLDL)在肝脏中的合成,增加循环中VLDL含量;Fox O1还可通过促进载脂蛋白CⅢ(Apo CⅢ)的表达,进而抑制脂蛋白酯酶(LPL)活性,减少循环中甘油三酯(TG)分解,导致高甘油三脂血症的发生;同时,Fox O1还能抑制固醇调节元件结合蛋白SREBP-1c表达,抑制脂肪合成。本文主要通过以上几个方面概述了Fox O1与肝脏脂代谢的影响。     

Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM)

In vertebrates, fibrinolysis is primarily carried out by the serine protease plasmin (Pm), which is derived from activation of the zymogen precursor, plasminogen (Pg). One of the most distinctive features of Pg/Pm is the presence of five homologous kringle (K) domains. These structural elements possess conserved Lys-binding sites (LBS) that facilitate interactions with substrates, activators, inhibitors and receptors. In human Pg (hPg), K2 displays weak Lys affinity, however the LBS of this domain has been implicated in an atypical interaction with the N-terminal region of a bacterial surface protein known as PAM (Pg-binding group A streptococcal M-like protein). A direct correlation has been established between invasiveness of group A streptococci and their ability to bind Pg. It has been previously demonstrated that a 30-residue internal peptide (VEK-30) from the N-terminal region of PAM competitively inhibits binding of the full-length parent protein to Pg. We have attempted to determine the effects of this ligand–protein interaction on the regulation of Pg zymogen activation and conformation. Our results show minimal effects on the sedimentation velocity coefficients (S°_20,w) of Pg when associated to VEK-30 and a direct relationship between the concentration of VEK-30 or PAM and the activation rate of Pg. These results are in contrast with the major conformational changes elicited by small-molecule activators of Pg, and point towards a novel mechanism of Pg activation that may underlie group A streptococcal (GAS) virulence.     

In vitro interactions of phenformin with serum lipoproteins and consequences thereof.

Turbidity developed when phenformin was added to human serum; this turbidity increased in a sigmoidal fashion with rising concentrations of phenformin (5–50 nmole/1). Centrifugation produced clearing of the solution, with collection of particulate matter on the surface of the sera.Extraction of control, and phenformin-treated sera with petroleum ether for 15 min. revealed that cholesterol and triglyceride were responsible for the turbidity. Different sera produced different turbidities with a given concentration of phenformin. No significant simple correlation existed between turbidity and serum cholesterol and/or triglyceride levels. The turbidities, produced by the addition of a constant concentration of phenformin to a series of diluted serum samples, were linearly related to the amount of serum present.The turbidities acquired by purified very-low density (VLDL), low-density (LDL), and high-density lipoprotein (HDL) fractions with phenformin were additive, and the turbidity of phenformin-treated serum was accounted for by these lipoprotein fractions. Serum free of lipoproteins did not become turbid when exposed to phenformin. Phenformin added to serum which had previously been delipidated, failed to produce turbidity. The turbidity produced by phenformin was reversible, because it could easily be cleared by dialysis.No significant differences in quantitative immunochemical reactivities were observed when control serum was compared with the subnatant of phenformin-treated serum, as determined by single radial immunodiffusion with LDL antibodies.These in vitro observations may be related to the in vivo hypolipidemic action of phenformin on hyperlipidemic subjects.     

LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) was originally identified as a receptor for oxidized low-density lipoprotein predominantly expressed in endothelial cells. LOX-1 expression can be induced in cardiomyocytes and that activation of LOX-1 is involved in apoptosis. To investigate possible roles of LOX-1 in myocardial ischemia-reperfusion injury, rats were subjected to coronary artery ligation for 1h followed by reperfusion for 2h. Immunohistochemistry revealed that expression of LOX-1 in cardiac myocytes was induced following ischemia-reperfusion but not ischemia alone. Administration of anti-LOX-1 monoclonal antibody resulted in a nearly 50% reduction in myocardial infarction size compared with that of normal IgG or saline (P<0.05). These findings suggest that activation of the LOX-1 pathway is involved in determining the extent of myocardial ischemia-reperfusion injury and that inhibition of the LOX-1 pathway may provide a novel strategy for treatment of acute myocardial infarction in humans.     

与紫云英转脂蛋白AsE246相互作用靶蛋白的筛选及其基因表达特征

【目的】AsE246是我们首次报道的紫云英根瘤特异表达的非特异性转脂蛋白(nsLTP1:non specificlipid transfer protein 1)编码基因。本实验旨在筛选和鉴定与AsE246相互作用的宿主植物靶蛋白,并分析靶基因在共生和胁迫条件下的表达特征。【方法】利用酵母双杂交技术、小范围杂交技术及实时荧光定量PCR,筛选与AsE246的相互作用蛋白,并定量分析靶基因在结瘤与固氮过程中的时空表达特性。【结果】获取一个阳性克隆,其cDNA序列经Blast分析表明:候选靶蛋白是一个DnaJ-like蛋白,该蛋白相应基因命名为AsDJL1。AsE246与AsDJL1在酵母体内确实相互作用。AsDJL1在固氮根瘤中特异性增强表达,在NaCl胁迫下表达水平显著提高,在(NH4)2SO4胁迫下表达水平显著下降。【结论】本实验是筛选与LTP相互作用蛋白的首次报道。获得了直接的实验证据表明互作基因AsDJL1与AsE246具有高度相似的表达特征和功能,为深入研究二者的相互作用及其在共生固氮和应答环境胁迫中的调控机制,提供了一定的工作基础和理论依据。     

CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis

CYP27A1, an enzyme involved in regulating cellular cholesterol homeostasis, converts cholesterol into 27-hydroxycholesterol (27-HC). The relationship between CYP27A1 and cell proliferation was studied to determine the role of CYP27A1 in bladder cancer. The expression of CYP27A1 in three bladder cancer cell lines (T24, UM-UC-3 and 5637) were assessed by qRT-PCR and Western blotting, and cells with stable CYP27A1 expression were generated by lentiviral infection. Cell proliferation was detected by MTT assays, colony formation assays and a tumor xenograft model in vitro and in vivo, and the intracellular 27-HC and cholesterol secretion levels were detected by enzyme-linked immunosorbent assays (ELISA). The results revealed that CYP27A1 expression was downregulated in androgen receptor (AR)-positive T24/UM-UC-3 cells compared with AR-negative 5637 cell. After CYP27A1 expression was restored, cell proliferation was inhibited in vitro and in vivo because much more intracellular 27-HC was produced in the CYP27A1-overexpressing cells than in the control cells. Both T24 and UM-UC-3 cells treated with 27-HC showed similar results. In addition, CYP27A1/27HC could reduce the cellular cholesterol level in both T24 and UM-UC-3 cells by upregulating ATP-binding cassette transporters G1 and A1 (ABCG1 and ABCA1) through Liver X receptors (LXRs) pathway and downregulating low-density lipoprotein receptor (LDLR) expression. These findings all suggest that CYP27A1 is a critical cholesterol sensor in bladder cancer cells that may contribute significantly to bladder cancer proliferation.     

重组猪溶素的生物学活性分析

摘要：【目的】 通过研究重组猪溶素（Recombinant Suilysin, rSLY）的生物学活性来分析猪溶素(Suilysin, SLY)在猪链球菌致病过程中的作用。【方法】 利用原核表达载体pET30a(+)表达SC22株猪链球菌的猪溶素基因（sly）,经Ni2+亲和柱、阴离子交换柱和凝胶过滤纯化获得rSLY制品。用微量法测定rSLY对人红细胞的溶血效价,用LDH法测定rSLY对人外周血白细胞、人胚胎肺源细胞、人胚胎肝细胞和人胚胎心肌细胞的毒性强度,并用水溶性胆固醇、人血清和特异性抗体阻断rSLY的溶血活性。用Luminex测定rSLY刺激小鼠后血清中前炎性细胞因子的浓度。【结果】我们测得重组猪溶素的溶血效价仅为0.125 nmol/L,但1 nmol/L rSLY对人外周血白细胞等的细胞毒性强度为20%～25%。水溶性胆固醇可阻断等摩尔浓度的rSLY,人血清样品（游离胆固醇的平均浓度为1～2 mmol/L）仅能阻断1 nmol/L rSLY的溶血作用。在人血清中添加15 mg/ml兔源抗猪溶素IgG可使10 nmol/L rSLY 的裂解强度从70%降到5%, 将猪溶素浓度提高到100 nmol/L时,红细胞裂解强度为60%。C57BL/6小鼠经腹腔注射rSLY后血清中白介素6、趋化因子KC持续上升,这与注射牛血清白蛋白的对照组小鼠血清中相应细胞因子浓度有显著性差异。【结论】 重组猪溶素不仅能直接损伤宿主细胞还能导致机体产生强烈的炎症反应,并进而损伤招募到炎症部位的免疫细胞;血清阻断rSLY溶血作用的能力很有限,特异性抗猪溶素抗体的保护作用表现为剂量依赖性。